NCT01770665

Brief Summary

Testing Mayo Clinic cancer patients with the results being correlated with prior patient therapy, performance status, and extent of disease.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2012

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

January 16, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 18, 2013

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2015

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
Last Updated

September 16, 2016

Status Verified

September 1, 2016

Enrollment Period

2.6 years

First QC Date

January 16, 2013

Last Update Submit

September 14, 2016

Conditions

Mesothelioma, Small Cell Lung Cancer, NSCLC

Outcome Measures

Primary Outcomes (1)

  • Complete response and survival

    1 year

Study Arms (2)

Mesothelioma

all cancer types

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

20 subjects diagnosed with mesothelioma and 10 diagnosed with any malignancy.

You may qualify if:

  • subjects diagnosed with mesothelioma and 10 diagnosed with any malignancy.

You may not qualify if:

  • patients that a sample cannot obtained for testing.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Validation Support Services 3050 Superior Drive NW

Rochester, Minnesota, 55901, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

Human cancerous tumor.

MeSH Terms

Conditions

MesotheliomaSmall Cell Lung CarcinomaCarcinoma, Non-Small-Cell Lung

Condition Hierarchy (Ancestors)

AdenomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsNeoplasms, MesothelialCarcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteLung DiseasesRespiratory Tract Diseases

Study Officials

  • Mary Karaus

    Mayo Clinic

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 16, 2013

First Posted

January 18, 2013

Study Start

June 1, 2012

Primary Completion

January 1, 2015

Study Completion

September 1, 2016

Last Updated

September 16, 2016

Record last verified: 2016-09

Locations

US(1)